HKSE - Delayed Quote HKD

Zhejiang Taimei Medical Technology Co., Ltd. (2576.HK)

3.320
-0.130
(-3.77%)
As of 2:33:23 PM GMT+8. Market Open.
Loading Chart for 2576.HK
  • Previous Close 3.450
  • Open 3.300
  • Bid 3.320 x --
  • Ask 3.430 x --
  • Day's Range 3.300 - 3.320
  • 52 Week Range 3.020 - 11.680
  • Volume 2,800
  • Avg. Volume 76,279
  • Market Cap (intraday) 1.872B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.420
  • Earnings Date Mar 24, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 6.65

Zhejiang Taimei Medical Technology Co., Ltd. provides digital operation platform for the biopharma industry in China. The company offers TrialOS, a drug digital cooperation platform that connects the cycle of hospitals, pharmaceutical companies, third-party providers, regulatory authorities, patients, and other industry stakeholders. It offers software solutions, such as eCooperate, a clinical trial project management system; eArchives, an electric trail master file; eCollect, an electronic data capture system; eCollege, a training management system; eQuality, a quality audit system; eBalance, an interactive Web-based response system; eOutcomes, a subject remote management system; eTime, a time management system; and eImage, a medical image reading system. It also provides hospital software, including eTrial, a phase I ward management system; eSite, a clinical trial management system; eMonitor, a remote site management system; eScreening, a subject screening system; GCP-X, an intelligent clinical trial platform; and IIT-EDC, a clinical research data collection system. In addition, the company offers pharmacovigilance software solutions, such as eSafety global pharmacovigilance system; and eSAE, a drug safety information communication ad management system. Further, it provides marketing software and digital innovation solutions. The company was founded in 2013 and is headquartered in Jiaxing, China.

www.taimei.com

627

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 2576.HK

View More

Performance Overview: 2576.HK

Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

2576.HK
22.43%
HANG SENG INDEX (^HSI)
16.86%

1-Year Return

2576.HK
70.46%
HANG SENG INDEX (^HSI)
22.90%

3-Year Return

2576.HK
70.46%
HANG SENG INDEX (^HSI)
17.80%

5-Year Return

2576.HK
70.46%
HANG SENG INDEX (^HSI)
1.50%

Compare To: 2576.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2576.HK

View More

Valuation Measures

Annual
As of 5/14/2025
  • Market Cap

    1.95B

  • Enterprise Value

    685.53M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.15

  • Price/Book (mrq)

    1.55

  • Enterprise Value/Revenue

    1.15

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -38.94%

  • Return on Assets (ttm)

    -10.94%

  • Return on Equity (ttm)

    -19.10%

  • Revenue (ttm)

    551.16M

  • Net Income Avi to Common (ttm)

    -214.61M

  • Diluted EPS (ttm)

    -0.420

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    978.7M

  • Total Debt/Equity (mrq)

    1.34%

  • Levered Free Cash Flow (ttm)

    -96.38M

Research Analysis: 2576.HK

View More

Company Insights: 2576.HK

Research Reports: 2576.HK

View More

People Also Watch